Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of LAMA3 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of LAMA3 mRNA | affects expression | 21346803
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of LAMA3 mRNA | decreases expression | 15982314
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of LAMA3 mRNA | decreases expression | 15982314
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LAMA3 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of LAMA3 mRNA | increases expression | 20458559
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of LAMA3 mRNA | increases expression | 16644059
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LAMA3 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LAMA3 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of LAMA3 mRNA | increases expression | 19619570
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of LAMA3 mRNA | affects cotreatment|decreases expression | 17404688
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased expression of LAMA3 mRNA | increases expression | 15541073
|
D008244 |
Lysophosphatidylcholines |
Lysophosphatidylcholines results in increased expression of LAMA3 mRNA | increases expression | 15541073
|
D015735 |
Mifepristone |
Mifepristone results in decreased expression of LAMA3 mRNA | decreases expression | 17584828
|
D009151 |
Mustard Gas |
Mustard Gas results in increased degradation of [LAMA3 protein binds to LAMB3 protein binds to LAMC2 protein] | affects binding|increases degradation | 18095945
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LAMA3 mRNA | decreases expression | 20059764 17426115
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LAMA3 mRNA] | decreases expression|increases reaction | 20059764
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of LAMA3 mRNA | affects cotreatment|decreases expression | 17404688
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of LAMA3 mRNA | decreases expression | 15982314
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of LAMA3 mRNA | increases expression | 20308225
|
C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate results in increased expression of LAMA3 mRNA | increases expression | 15541073
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LAMA3 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LAMA3 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LAMA3 mRNA | increases expression | 12377990
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of LAMA3 mRNA | decreases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of LAMA3 mRNA | decreases expression | 15982314
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of LAMA3 mRNA | increases expression | 17982090
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of LAMA3 mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
19.36 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
19.36 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
19.36 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
19.36 | 7525203 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.86 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.16 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.35 | 16185265 18769834 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.28 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.28 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.46 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.46 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.57 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.77 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.51 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.85 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.85 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.03 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
20.95 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
20.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
20.95 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
20.95 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.21 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.13 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.30 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.30 | 17261762 17289903 19861407 12948864 14630087 16675129 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.30 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.30 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.30 | 16873071 16443354 16166294 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.03 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.85 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.20 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.33 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.65 | 16011737 15721981 16124888 15673190 18705752 16227642 16097048 15700767 10355542 16050911 3786805 16192424 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.12 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
11.12 | 11135700 14691202 15553829 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.12 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.12 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.12 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.12 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.75 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.00 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
7.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.47 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.47 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
12.11 | 14694615 |
MESH:D002386 |
Cataract |
|
Tretinoin |
12.11 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
12.11 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.65 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.65 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.65 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.43 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.43 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.58 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.58 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.34 | 17035595 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
9.34 | 16782535 17936198 16867261 16474422 18023891 18200517 17991707 16804969 11698051 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.40 | 17276891 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
14.95 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
14.95 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
14.95 | 15095906 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.06 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.33 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
5.33 | 9879862 18769834 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.33 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.33 | 9224671 16925845 14991402 10589399 9125849 17551590 9664655 9211117 9142499 8800419 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.79 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
10.79 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.97 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.30 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.36 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.62 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
11.62 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.62 | 6623471 15968718 15998439 10915739 6884620 16227642 7120509 17522070 3732212 11566570 10092053 16177239 3786805 9327722 15027814 19085960 7179309 2869522 19336974 21278145 7440962 4309450 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.62 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
11.62 | 18551238 21346803 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.66 | 11462148 |
MESH:D004487 |
Edema |
|
Mustard Gas |
10.73 | 11428631 11428647 11402378 9260866 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.73 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.73 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.51 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.51 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.65 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.13 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.13 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
14.66 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
14.66 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
14.66 | 10568697 9294722 |
OMIM:226700 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE |
marker/mechanism |
|
| |
OMIM:226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE |
marker/mechanism |
|
| |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.03 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.28 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.51 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.51 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
17.76 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.76 | 15959796 16239168 12795759 16045604 12631006 19224547 17595544 61145 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.76 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.76 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
26.36 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
26.36 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
26.36 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
26.36 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
26.36 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.13 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.55 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.09 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.92 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.31 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.31 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.46 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.29 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.47 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.73 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.73 | 16120746 12621046 15340226 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
13.73 | 15817613 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.90 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.04 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.62 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.11 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.40 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.78 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.78 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.96 | 15338365 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.27 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.79 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
6.79 | 12150543 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
7.96 | 11428620 11428631 9260866 16001271 8975870 11402378 11428647 9357497 17524151 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.96 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.96 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.53 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.91 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.91 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
9.55 | 17994277 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
9.55 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.53 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.53 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.31 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.51 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.62 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.62 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.62 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.74 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.74 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.74 | 15610895 |
OMIM:245660 |
LARYNGOONYCHOCUTANEOUS SYNDROME |
marker/mechanism |
|
| |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.13 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.13 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.67 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.18 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.33 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.07 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.07 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.80 | 19850784 16467208 20471514 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.80 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.35 | 17869043 17649720 16330433 15213294 15336539 19075265 16331271 19035177 12018890 12712474 19225113 17107899 15748426 9834237 11468182 19642359 17217047 16112521 12679006 16823087 16966277 17712046 11161223 16891316 15622746 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.35 | 19035177 17712046 17649720 15748426 17301526 16766008 17339181 19225113 16891316 17368321 17361223 17217047 17294898 19029980 16935935 12679006 19642359 17506722 16823087 16140955 19075265 16331271 17107899 16788101 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.22 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.74 | 16943688 16239168 11408273 17174718 21278145 11903743 17334410 16221502 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.55 | 15338365 12445418 17805973 16015684 18210741 16033810 17708605 17823541 16248980 12666154 12667390 15370692 18166357 14512876 18205269 18395914 17721639 18472094 12586293 17557913 15893842 18277467 17631135 17869086 15650968 14748882 18418968 14716496 12958196 17922224 17976157 14620537 16097048 18006644 16027843 15931870 18705752 17481882 10355542 17698563 15959796 15818738 11481614 12546737 15362042 17761835 17565644 17900296 15123356 18054572 12445421 18472332 16116963 16136751 18429990 12649538 15057751 17714472 15673190 12389079 18420326 18251166 12632512 18376398 13678700 12898905 14724832 16638106 17525996 15925388 18263696 18412020 12609069 12741479 18279442 14716833 15052691 17766677 18395095 18317297 16192424 18339082 15730626 18481824 12632514 20821823 15996030 17944888 16011737 18187930 15876570 17640975 18156304 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.55 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.55 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.55 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.55 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.05 | 17285989 16246199 16964402 15830285 15720792 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.03 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.57 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
13.71 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
13.71 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.71 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.71 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.71 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.34 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.34 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.34 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.25 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.25 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.25 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.36 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.36 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
8.36 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
8.36 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.36 | 19931552 17306315 17077188 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.36 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.78 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.78 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.35 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.12 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.12 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.12 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.66 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.01 | 14977855 19417148 19549372 15949261 11468182 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.54 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.14 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.14 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.09 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.91 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.91 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.24 | 18551238 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
10.24 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.83 | 16624393 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
11.36 | 16946489 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.36 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.36 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.36 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.54 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.60 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.17 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.59 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.59 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.59 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.66 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.66 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.66 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
3.98 | 17368321 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.85 | 7688884 16761898 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
14.61 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
14.61 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
14.61 | 14694615 17852074 12819281 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
18.34 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
18.34 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
18.34 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
18.34 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
18.34 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
18.34 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.80 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.13 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.13 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.08 | 17698068 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.04 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.67 | 15727166 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.87 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.11 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
9.41 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.41 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.76 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.60 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.60 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.60 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.48 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.96 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.79 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.88 | 17720292 17894541 10334151 17266442 17620002 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.98 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.81 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.83 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.90 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
5.90 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.68 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.07 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.07 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.07 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.15 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.69 | 12854658 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.07 | 15817613 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.42 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.42 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.88 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.88 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.56 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.83 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.04 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.04 | 12973940 12845720 11780464 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.04 | 16452187 17306315 11723127 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.18 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.02 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.02 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.48 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.85 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.29 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
therapeutic |
|
| 15541073 |
MESH:D014947 |
Wounds and Injuries |
|
lysophosphatidic acid |
14.34 | 15541073 |
MESH:D014947 |
Wounds and Injuries |
|
Lysophosphatidylcholines |
14.34 | 15541073 |
MESH:D014947 |
Wounds and Injuries |
|
sphingosine 1-phosphate |
14.34 | 15541073 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.31 | 17120751 |